PharVision Advisers’s OraSure Technologies OSUR Stock Holding History

PharVision Advisers’s Portfolio OSUR Stock Details OSUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$40.7K	Buy	+10,380	New	+$40.1K	1.65%	22

Other funds holding OSUR

Private Management Group Irvine, California $3.63B AUM 11.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return

Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

KLP Kapitalforvaltning Oslo, Norway $32.3B AUM 34.58% 1-Year Est. Return

PharVision Advisers's OSUR Position: Q3 2026 in Review

PharVision Advisers opened a new position in OraSure Technologies (OSUR) in Q3 2026: 10,380 shares worth $40.7K. The stake represents 1.65% of the portfolio and ranks #22 among its holdings.

61 funds tracked by Wall St. Rank hold OSUR as of Q3 2026.

PharVision Advisers held 10,380 shares of OraSure Technologies worth $40.7K as of Q3 2026.
OraSure Technologies was a new PharVision Advisers position in Q3 2026.
OraSure Technologies made up 1.65% of PharVision Advisers's portfolio in Q3 2026, its #22 holding.
61 funds tracked by Wall St. Rank held OraSure Technologies as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.